非增强磁共振小肠造影在诊断或疑似炎症性肠病患儿中检测活动性肠道炎症的诊断准确性:以确定钆对比剂的必要性
回顾性研究纳入77例已知或疑似炎症性肠病的7-18岁患儿,在磁共振小肠造影前后由两名放射科医生评估肠道及非肠道表现,对照30天内内镜活检参考标准。非增强与增强前后图像在检测活动性炎症方面敏感度均为67%,特异度分别为80%和68%,差异不大;增强后检出更多穿透性并发症(P=0.04)。结论认为对比剂未提高末端回肠和结肠活动性炎症的检出,但有助于发现穿透性疾病。
要点
- 非增强与增强前后磁共振小肠造影检测活动性炎症的敏感度均为67%,特异度分别为80%和68%。
- 增强后图像可检出更多穿透性并发症(P=0.04)。
- 非增强与增强前后图像判读与内镜/组织病理结果的一致度均为中等(κ分别为0.42和0.32)。
核心结论
- 使用对比剂并未提高末端回肠和结肠活动性炎症的检出,但有助于发现穿透性疾病。
研究设计与样本
- 回顾性研究纳入77例(7-18岁;68.8%男性)已知(n=58)或疑似(n=19)炎症性肠病患儿,在磁共振小肠造影前后30天内完成内镜活检,两名放射科医生分三次判读增强前、增强后及增强前后图像,第三名放射科医生独立判读27例评估读者间可靠性,参考标准为内镜/组织病理联合结果。
关键影像表现/征象
- 增强后检出更多穿透性并发症(P=0.04)。
诊断标准与关键数值
- 非增强与增强前后磁共振小肠造影对照内镜/组织病理联合结果的一致度为85.7%(κ=0.713,P<0.001;P=0.549)。
- 非增强与增强前后磁共振小肠造影检测活动性炎症的敏感度均为67%(95%CI 0.53-0.79 vs 67%,95%CI 0.53-0.79)。
- 非增强与增强前后磁共振小肠造影检测活动性炎症的特异度分别为80%(95%CI 0.59-0.92)和68%(95%CI 0.46-0.84)。
- 非增强与增强前后磁共振小肠造影判读与参考标准的一致度分别为κ=0.42(P<0.001)和κ=0.32(P=0.003)。
- 三名读者间一致度为85.2%(κ=0.695,P=0.001;P=0.625)。
临床应用与阅片要点
- 在评估末端回肠和结肠活动性炎症时,非增强磁共振小肠造影与增强前后图像诊断准确性相近。
- 增强后图像有助于检出穿透性并发症。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Pediatric patients with inflammatory bowel disease (IBD) are at increased risk of gadolinium deposition given the potential need for multiple contrast-enhanced magnetic resonance enterography (MRE) exams over their lifetime.
OBJECTIVE: To determine whether gadolinium-based contrast agents are necessary in assessing active bowel inflammation on MRE in pediatric patients with known or suspected IBD.
MATERIALS AND METHODS: We conducted a retrospective study of 77 patients (7-18 years; 68.8% male) with known (n=58) or suspected (n=19) IBD and endoscopy with biopsy performed within 30 days of MRE without and with contrast evaluated bowel and non-bowel findings. During three visual analysis sessions, two radiologists reviewed pre-, post-, and pre-/post-contrast MRE images. A third radiologist independently reviewed 27 studies to assess inter-reader reliability. We used Cohen kappa (κ), Fleiss kappa, (κF), McNemar test, and sensitivity and specificity to compare MRE readings to combined endoscopic/histopathological findings (the reference standard).
RESULTS: The pre- and pre-/post-contrast-enhanced MRE vs. combined endoscopic/histopathological results had moderate agreement (85.7%; κ 0.713, P<0.001; P-value 0.549). Compared to combined endoscopy/histopathology, pre- vs. pre-/post-contrast sensitivity (67%, confidence interval [CI] 0.53-0.79 vs. 67%, CI 0.53-0.79) and specificity (80%, CI 0.59-0.92 vs. 68%, CI 0.46-0.84) varied little (κ 0.42, P<0.001 and κ 0.32, P=0.003, respectively). The three readers had moderate agreement (85.2%; κ 0.695, P=0.001; P-value 0.625). More penetrating complications were identified following contrast administration (P-value 0.04).
CONCLUSION: Use of a contrast agent does not improve the detection of active inflammation in the terminal ileum and colon compared to non-contrast MRE, although use of a contrast agent does aid in the detection of penetrating disease.
引用
- Kim SJ, Ratchford TL, Buchanan PM, et al. Diagnostic accuracy of non-contrast magnetic resonance enterography in detecting active bowel inflammation in pediatric patients with diagnosed or suspected inflammatory bowel disease to determine necessity of gadolinium-based contrast agents. Pediatr Radiol. 2019. PMID: 30899973. doi:10.1007/s00247-019-04369-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。